Blood and Lymph Conditions

All Conditions

Neoplasms

Skin and Connective Tissue Diseases

Symptoms and General Pathology

Behaviors and Mental Disorders

Lymphedema

Breast Neoplasms

Breast Cancer Lymphedema

Breast Diseases

Skin Diseases

Lymphatic Diseases

Quality of Life

Standard of Care plus Lymphatic massage (Decongestive Lymphatic Therapy)

20 weeks of lymphatic massage therapy by a certified LMT in the Vodder technique Elastic Compression Sleeve and GLove

Lymphatic Massage (Decongestive Lymphatic Therapy) (Arm 1)

Ian Dayes, MD

Tim Whelan, MD

Jim Julian, M. Math

Lyn Kligman, RN

Kathy Pritchard, MD

The purpose of this study is to evaluate the efficacy, safety and impact on quality of life of decongestive lymphatic therapy (DLT) in women who have completed treatment for breast cancer and present with lymphedema.

This is a multicentre trial enrolling 100 patients randomized to receive conservative care for arm lymphedema (Canadian Guidelines) with or without decongestive lymphatic therapy performed by a professional who has received training and certification in the technique of lymphatic draining massage.

Duration: One year after the last patient is randomized.

Randomized patients receive either standard of care or standard of care plus DLT (five massage sessions per week for 4 consecutive weeks). Primary evaluation of all patients is recorded six weeks after randomization by measuring the affected limb and comparing with the unaffected one. There is an extended follow-up of one year.

Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY"

DELTA - A Randomized Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer

Canadian Breast Cancer Research Alliance

Ontario Clinical Oncology Group (OCOG)

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY"	NCT00201890	Breast Cancer Lymphedema	Lymphatic Massa...	18 Years -	Ontario Clinical Oncology Group (OCOG)
Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY"	NCT00201890	Breast Cancer Lymphedema	Lymphatic Massa...	18 Years -	Ontario Clinical Oncology Group (OCOG)

Spots Global Cancer Trial Database for decongestive therapy